Stryker Stock Today

SYK Stock  USD 369.53  5.87  1.61%   

Performance

Very Weak

 
Weak
 
Strong

Odds Of Distress

Low

 
High
 
Low
Stryker is selling for 369.53 as of the 15th of March 2025. This is a 1.61% increase since the beginning of the trading day. The stock's last reported lowest price was 362.61. Stryker has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Note, on February 11, 2025, Representative Jared Moskowitz of US Congress acquired under $15k worth of Stryker's common stock.
Business Domain
Health Care Equipment & Services
IPO Date
1st of February 1988
Category
Healthcare
Classification
Health Care
Stryker Corporation operates as a medical technology company. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan. Stryker Corp operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. The company has 381.58 M outstanding shares of which 4.73 M shares are at this time shorted by investors with about 3.46 days to cover. More on Stryker

Moving against Stryker Stock

  0.39EMBC Embecta CorpPairCorr
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores

Stryker Stock Highlights

ESG Sustainability
Environmental
Governance
Social
ChairmanKevin Lobo
Thematic Ideas
(View all Themes)
Old NameStryker Corporation
Business ConcentrationHealth Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NYSE Composite, Nasdaq CTA Artificial, SP 500 Index, ARCA Institutional, BETTERINVESTING 100 INDEX, BTRINVSTNG 100 INDEX, Obamacare Repeal, Healthcare, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors)
Excise Tax ActivitiesAnimal Testing
Average Analyst Recommendation
Debt Levels
Stryker can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Stryker's financial leverage. It provides some insight into what part of Stryker's total assets is financed by creditors.
Liquidity
Stryker has 1.41 B in debt with debt to equity (D/E) ratio of 0.88, which is OK given its current industry classification. Stryker has a current ratio of 1.96, which is typical for the industry and considered as normal. Note however, debt could still be an excellent tool for Stryker to invest in growth at high rates of return.

Other Cashflows From Financing Activities

(233.7 Million)
Stryker (SYK) is traded on New York Stock Exchange in USA. It is located in 1941 Stryker Way, Portage, MI, United States, 49002 and employs 53,000 people. Stryker is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Mega-Cap' category with a total capitalization of 141 B. Stryker runs under Health Care Equipment & Supplies sector within Health Care industry. The entity has 381.58 M outstanding shares of which 4.73 M shares are at this time shorted by investors with about 3.46 days to cover. Stryker has about 1.84 B in cash with 4.24 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.98.
Check Stryker Probability Of Bankruptcy
Ownership Allocation
Stryker shows a total of 381.58 Million outstanding shares. The majority of Stryker outstanding shares are owned by institutional holders. These institutional investors are usually referred to as non-private investors looking to take positions in Stryker to benefit from reduced commissions. Consequently, institutions are subject to a different set of regulations than regular investors in Stryker. Please pay attention to any change in the institutional holdings of Stryker as this could imply that something significant has changed or is about to change at the company. Please note that on February 11, 2025, Representative Jared Moskowitz of US Congress acquired under $15k worth of Stryker's common stock.
Check Stryker Ownership Details

Stryker Stock Institutional Holders

InstituionRecorded OnShares
Bank Of New York Mellon Corp2024-12-31
5.4 M
Fundsmith Llp2024-12-31
5.3 M
Norges Bank2024-12-31
4.8 M
Fisher Asset Management, Llc2024-12-31
4.1 M
Northern Trust Corp2024-12-31
3.6 M
Franklin Resources Inc2024-12-31
3.5 M
First Western Trust Bank2024-12-31
3.5 M
Bank Of America Corp2024-12-31
M
Mackenzie Investments2024-12-31
2.8 M
Vanguard Group Inc2024-12-31
32.7 M
Blackrock Inc2024-12-31
26.8 M
View Stryker Diagnostics

Stryker Historical Income Statement

At this time, Stryker's Operating Income is quite stable compared to the past year. EBIT is expected to rise to about 4.9 B this year, although the value of Non Operating Income Net Other will most likely fall to (149.3 M). View More Fundamentals

Stryker Stock Against Markets

Stryker Corporate Directors

Andrew SilvernailIndependent DirectorProfile
Sherilyn McCoyIndependent DirectorProfile
Ronda StrykerIndependent DirectorProfile
Allan GolstonLead Independent DirectorProfile
When determining whether Stryker is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Stryker Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Stryker Stock. Highlighted below are key reports to facilitate an investment decision about Stryker Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Stryker. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.
For more information on how to buy Stryker Stock please use our How to buy in Stryker Stock guide.
You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Stryker. If investors know Stryker will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Stryker listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.53)
Dividend Share
3.24
Earnings Share
7.76
Revenue Per Share
59.304
Quarterly Revenue Growth
0.107
The market value of Stryker is measured differently than its book value, which is the value of Stryker that is recorded on the company's balance sheet. Investors also form their own opinion of Stryker's value that differs from its market value or its book value, called intrinsic value, which is Stryker's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Stryker's market value can be influenced by many factors that don't directly affect Stryker's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Stryker's value and its price as these two are different measures arrived at by different means. Investors typically determine if Stryker is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Stryker's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.